Andrew Huberman· PhD
But we've got psilocybin designated for two separate entities as a breakthrough therapy by the FDA, and people may not realize, and the MDMA is designated as a breakthrough therapy for PTSD.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But we've got psilocybin designated for two separate entities as a breakthrough therapy by the FDA, and people may not realize, and the MDMA is designated as a breakthrough therapy for PTSD.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And because it was only just a few years ago really, only about five years ago, that psychedelics including psilocybin received what's called a breakthrough status at the FDA.